動物用抗生物質および抗菌剤の世界市場:製品別、動物タイプ別2026年予測
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026
- 出版元:MarketsandMarkets
出版元について - 発行年:2020年3月
 - 定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
 - ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
 - ご請求は円換算(お見積り日TTSレート)となります。
 - 納品形態:PDF by Email
 - 当調査レポートは英文248ページになります。
 - 商品コード:MAM2354
 
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
                      

                      
                      
                      【レポート紹介】
                      動物用抗生物質および抗菌剤の世界市場規模は、2021年の47億ドルから2026年には56億ドルへと漸増が予測されます。 
レポートは動物用抗生物質および抗菌剤の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。また市場をさまざまな切り口で細分化し、そのセグメント市場ごとの市場予測を中心に構成されています。当レポートでの各種セグメント市場の区分および項目は、製品別市場、デリバリータイプ別市場、動物タイプ別市場、および主要国地域別市場、などとなっています。また競合状況、主要企業情報(15社)、COVID-19の影響分析、バリューチェーン分析などの分析情報も加味し、動物用抗生物質および抗菌剤市場の今後成長性および動向を詳細にレポートしています。 
【レポート構成概要】 
                      ◆動物用抗生物質および抗菌剤の世界市場予測2018-2026年 
                      ・市場規模(US$)
                    
◆製品別、市場-2026年 
                      ・テトラサイクリン 
                      ・ペニシリン 
                      ・サルファ剤 
                      ・マクロライド 
                      ・アミノグリコシド 
                      ・リンコサミド 
                      ・フルオロキノロン 
                      ・セファロスポリン 
                      ・その他抗生物質および抗菌剤 
                      ※(市場規模US$)  
◆デリバリータイプ別、市場-2026年 
                      ・プレミックス 
                      ・経口液剤 
                      ・経口粉末 
                      ・注射 
                      ・その他デリバリータイプ 
                      ※(市場規模US$) 
◆動物タイプ別、市場-2026年 
                      食料生産動物 
                      ・牛 
                      ・豚 
                      ・家禽 
                      ・羊/ヤギ 
                      ・その他食料生産動物 
コンパニオンアニマル 
                      ・犬 
                      ・猫 
                      ・馬 
                      ・その他コンパニオンアニマル 
                      ※(市場規模US$) 
◆主要国地域別市場-2026年 
                      北米 
                      ・米国、カナダ 
                      欧州 
                      ・スペイン、イタリア、ドイツ 
                      ・フランス、英国 
                      ・その他欧州 
                      アジア太平洋 
                      ・日本、中国、インド 
                      ・その他アジア太平洋 
                      中南米 
                      中東アフリカ 
                      ※国地域別に全セグメントの細分化データ掲載、詳細は目次参照 
◆市場分析 
                      ・市場ダイナミクス分析(ドライバー、障壁、機会、課題) 
                      ・業界動向 
                      ・COVID-19の影響の分析 
                      ・規制分析 
                      ・バリューチェーン分析 
                      ・エコシステム市場マップ 
                      ・ファイブフォース分析 
                      ・サプライチェーン分析 
                      ・特許分析 
                      ・価格分析 
                      ・市場シェア分析 
                      ・競合状況 
◆動物用抗生物質および抗菌剤の主要企業プロフィール動向 
                      ・ZOETIS, INC.
                      ・MERCK & CO., INC.
                      ・BOEHRINGER INGELHEIM GMBH
                      ・ELANCO ANIMAL HEALTH
                      ・CEVA SANTÉ ANIMALE
                      ・VIRBAC
                      ・VETOQUINOL SA.
                      ・DECHRA PHARMACEUTICALS PLC
                      ・PHIBRO ANIMAL HEALTH
                      ・共立製薬株式会社 
                      ・ZYDUS ANIMAL HEALTH
                      ・TIANJIN RINGPU
                      ・HIPRA
                      ・CHINA ANIMAL HUSBANDRY
                      ・INOVET
(その他企業)
                      ・ENDOVAC ANIMAL HEALTH  
                      ・ECO ANIMAL HEALTH GROUP PLC    
                      ・INDIAN IMMUNOLOGICALS LTD.       
                      ・ASHISH LIFE SCIENCE (ALS)   
                      ・LUTIM PHARMA
                      (全248頁) 
                      【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026
Table of Contents
1.... INTRODUCTION
1.1             OBJECTIVES OF THE STUDY 
                            1.2             MARKET DEFINITION 
                            1.2.1              INCLUSIONS AND EXCLUSIONS 
                            1.2.2              MARKETS COVERED.. 34 
                            1.2.3              YEARS CONSIDERED FOR THE STUDY 
                            1.3             CURRENCY 
                            ・       TABLE 1........ EXCHANGE RATES UTILIZED FOR CONVERSION  TO USD 
                            1.4             LIMITATIONS 
                            1.5             STAKEHOLDERS 
                            1.6             SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1             RESEARCH DATA 
                            ・       FIGURE 1.................................................. RESEARCH DESIGN.. 37 
                            2.1.1              SECONDARY DATA 
                            2.1.1.1            KEY DATA FROM SECONDARY SOURCES 
                            2.1.2              PRIMARY DATA 
                            ・       FIGURE 2.................................................. PRIMARY SOURCES.. 39 
                            2.1.2.1            KEY DATA FROM PRIMARY SOURCES 
                            2.1.2.2            KEY INDUSTRY INSIGHTS 
                            ・       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,  DESIGNATION, AND REGION 
                            2.2             MARKET SIZE ESTIMATION 
                            ・       FIGURE 4. SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE  ANALYSIS 
                            ・       FIGURE 5..................... REVENUE SHARE ANALYSIS ILLUSTRATION 
                            ・       FIGURE 6..................... COUNTRY-LEVEL ANALYSIS OF THE ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET 
                            ・       FIGURE 7................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 
                            ・       FIGURE 8.............................................. TOP-DOWN APPROACH.. 45 
                            2.3             MARKET BREAKDOWN & DATA TRIANGULATION 
                            ・       FIGURE 9............... MARKET DATA TRIANGULATION METHODOLOGY 
                            2.4             MARKET SHARE ANALYSIS 
                            2.5             ASSUMPTIONS FOR THE STUDY
3.... EXECUTIVE SUMMARY
・       FIGURE 10. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  PRODUCT, 
                            2021 VS. 2026 (USD MILLION) 
                            ・       FIGURE 11.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET, 
                            BY MODE OF DELIVERY, 2021 VS. 2026 (USD MILLION) 
                            ・       FIGURE 12. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  ANIMAL TYPE, 2021 VS. 2026 (USD MILLION) 
                            ・       FIGURE 13....... GEOGRAPHICAL SNAPSHOT OF THE GLOBAL  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
4.... PREMIUM INSIGHTS
4.1             ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET OVERVIEW 
                            ・       FIGURE 14 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS AND  GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH 
                            4.2             ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,  BY MODE OF DELIVERY AND COUNTRY (2020) 
                            ・       FIGURE 15...... CHINA ACCOUNTED FOR THE LARGEST SHARE OF  THE APAC ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2020 
                            4.3             ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHIC  GROWTH OPPORTUNITIES 
                            ・       FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING  THE FORECAST PERIOD 
                            4.4             REGIONAL MIX: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET  (2021−2026) 
                            ・       FIGURE 17....... NORTH AMERICA WILL CONTINUE TO DOMINATE  THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2026.. 54 
                            4.5             ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: DEVELOPED VS.  DEVELOPING MARKETS 
                            ・       FIGURE 18... DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES  DURING THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1             INTRODUCTION 
                            5.2             MARKET DYNAMICS 
                            ・       TABLE 2 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES:  IMPACT ANALYSIS 
                            5.2.1              DRIVERS 
                            5.2.1.1            RISING  DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS 
                            ・       TABLE 3.... PAST AND PROJECTED TRENDS IN THE  CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS 
                            ・       FIGURE 19......... ASIA: COUNTRY-LEVEL CONSUMPTION OF  ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 
                            ・       FIGURE 20 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED  FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 
                            ・       FIGURE 21.. ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN  THE WORLD IN 2018 
                            5.2.1.2            INCREASING  INCIDENCE OF ZOONOTIC DISEASES 
                            ・       TABLE 4.. ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES  (2009–2019) 
                            5.2.1.3            INCREASING  INVESTMENTS FROM PRIVATE PLAYERS 
                            5.2.1.4            RISING  DEMAND FOR PET INSURANCE AND GROWING ANIMAL HEALTH EXPENDITURE 
                            ・       FIGURE 22....... NORTH AMERICA: PET HEALTH INSURANCE  MARKET, 
                            2014 VS. 2019 (USD MILLION) 
                            5.2.2              RESTRAINTS 
                            5.2.2.1            LIMITED  NUMBER OF NEW ANTIBIOTICS 
                            5.2.2.2            GROWING  RESISTANCE TO ANTIMICROBIALS AND ANTIBIOTICS 
                            5.2.2.3            ROUTINE  PROPHYLACTIC USE OF ANTIBIOTICS BEING REPLACED BY GOOD HUSBANDRY, PROBIOTICS,  AND HYGIENE PRACTICES 
                            5.2.3              OPPORTUNITIES 
                            5.2.3.1            UNTAPPED  EMERGING MARKETS 
                            5.2.3.2            GROWTH IN  THE COMPANION ANIMAL POPULATION 
                            ・       TABLE 5......... US: COMPANION ANIMAL POPULATION  (2010–2025) 
                            ・       TABLE 6........ UK : COMPANION ANIMAL POPULATION  (2010–2025) 
                            ・       TABLE 7. INDIA : COMPANION ANIMAL POPULATION IN (2010–2025) 
                            ・       TABLE 8.. SAUDI ARABIA: COMPANION ANIMAL POPULATION  (2010–2025) 
                            5.2.4              CHALLENGES 
                            5.2.4.1            STRINGENT  APPROVAL PROCESS FOR ANTIMICROBIALS AND ANTIBIOTICS
6.... INDUSTRY INSIGHTS
6.1             INTRODUCTION 
                            6.2             COVID-19 IMPACT ANALYSIS 
                            6.2.1              IMPACT OF COVID-19 ON THE ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET 
                            6.3             INDUSTRY TRENDS 
                            ・       FIGURE 23........ GROWING CONSOLIDATION IN THE ANIMAL  HEALTH INDUSTRY IS A MAJOR TREND IN THE ANIMAL ANTIMICROBIALS & ANTIBIOTICS  MARKET 
                            6.3.1              GROWING CONSOLIDATION IN THE ANIMAL  HEALTH INDUSTRY 
                            ・       TABLE 9.......... SOME MAJOR ACQUISITIONS IN THE ANIMAL  HEALTH INDUSTRY 
                            (2017–2019) 
                            6.3.2              GROWING FOCUS ON LIMITING THE USE OF  ANTIBIOTICS IN LIVESTOCK ANIMALS 
                            6.3.3              HIGH GROWTH IN EMERGING MARKETS 
                            6.4             REGULATORY ANALYSIS 
                            ・       FIGURE 24... DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL  PHARMACEUTICAL PRODUCTS 
                            6.5             VALUE CHAIN ANALYSIS 
                            ・       FIGURE 25 ANIMAL ANTIMICROBIALS AND ANTIBODY MARKET: VALUE  CHAIN ANALYSIS 
                            6.6             ECOSYSTEM MARKET MAP 
                            ・       TABLE 10...... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: ECOSYSTEM MAPPING 
                            ・       FIGURE 26.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: ECOSYSTEM MARKET MAP 
                            6.7             PORTER’S FIVE FORCES ANALYSIS 
                            ・       TABLE 11...... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: PORTER’S FIVE FORCES ANALYSIS 
                            6.7.1              THREAT FROM NEW ENTRANTS 
                            6.7.2              THREAT FROM SUBSTITUTES 
                            6.7.3              BARGAINING POWER OF SUPPLIERS 
                            6.7.4              BARGAINING POWER OF BUYERS 
                            6.7.5              INTENSITY OF COMPETITIVE RIVALRY 
                            6.8             SUPPLY CHAIN ANALYSIS 
                            ・       FIGURE 27.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: SUPPLY CHAIN ANALYSIS 
                            6.9             PATENT ANALYSIS 
                            ・       TABLE 12............... LIST OF ANTIBIOTICS AND THEIR PATENT  YEARS 
                            6.10          PRICING ANALYSIS
7.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT
7.1             INTRODUCTION 
                            ・       FIGURE 28.. SALES OF ANTIMICROBIAL AGENTS, BY ANTIMICROBIAL  CLASS, AS A PERCENTAGE OF THE TOTAL SALES FOR FOOD-PRODUCING SPECIES (IN  MG/PCU): AGGREGATED BY 31 EUROPEAN COUNTRIES, 2018 
                            ・       TABLE 13... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  PRODUCT, 
                            2019–2026 (USD MILLION) 
                            ・       TABLE 14... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  COUNTRY, 
                            2019–2026 (USD MILLION) 
                            7.2             TETRACYCLINES 
                            7.2.1              REDUCED COST OF TETRACYCLINES IS A KEY  FACTOR DRIVING MARKET GROWTH ACROSS THE GLOBE 
                            ・       TABLE 15......... TETRACYCLINES OFFERED BY KEY MARKET  PLAYERS 
                            ・       FIGURE 29......... SALES OF TETRACYCLINES FOR  FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 16. TETRACYCLINES MARKET, BY COUNTRY, 2019–2026 (USD  MILLION) 
                            7.3             PENICILLINS 
                            7.3.1              RISING INCIDENCE OF ZOONOTIC DISEASES IN  LIVESTOCK ANIMALS TO DRIVE THE DEMAND FOR PENICILLINS 
                            ・       TABLE 17.............. PENICILLINS OFFERED BY KEY MARKET  PLAYERS 
                            ・       FIGURE 30 SALES OF PENICILLINS FOR FOOD-PRODUCING ANIMALS IN  EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 18..... PENICILLINS MARKET, BY COUNTRY,  2019–2026 (USD MILLION) 
                            7.4             SULFONAMIDES 
                            7.4.1              REDUCED COST AND MULTIPLE APPLICATIONS  IN LIVESTOCK INFECTIONS TO DRIVE THE DEMAND FOR SULFONAMIDES IN RURAL REGIONS 
                            ・       TABLE 19......... SULFONAMIDES OFFERED BY KEY MARKET PLAYERS 
                            ・       FIGURE 31........ SALES OF SULFONAMIDES FOR FOOD-PRODUCING  ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 20. SULFONAMIDES MARKET, BY COUNTRY, 2019–2026 (USD  MILLION) 
                            7.5             MACROLIDES 
                            7.5.1              INCREASING PRODUCTION OF CATTLE-DERIVED  FOOD PRODUCTS TO BOOST THE DEMAND FOR MACROLIDES 
                            ・       TABLE 21............ MACROLIDES OFFERED BY KEY MARKET PLAYERS 
                            ・       FIGURE 32 SALES OF MACROLIDES FOR FOOD-PRODUCING ANIMALS IN  EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 22.... MACROLIDES MARKET, BY COUNTRY, 2019–2026  (USD MILLION) 
                            7.6             AMINOGLYCOSIDES 
                            7.6.1              AMINOGLYCOSIDES ARE COMMONLY USED TO  CONTROL LOCAL AND SYSTEMIC INFECTIONS CAUSED BY SUSCEPTIBLE AEROBIC BACTERIA  (GENERALLY GRAM-NEGATIVE) 
                            ・       TABLE 23.... AMINOGLYCOSIDES OFFERED BY KEY MARKET PLAYERS 
                            ・       FIGURE 33.... SALES OF AMINOGLYCOSIDES FOR  FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 24... AMINOGLYCOSIDES MARKET, BY COUNTRY, 2019–2026 (USD  MILLION) 
                            7.7             LINCOSAMIDES 
                            7.7.1              LINCOSAMIDES EXHIBIT SERIOUS SIDE EFFECTS—A  KEY FACTOR LIMITING MARKET GROWTH 
                            ・       TABLE 25.......... LINCOSAMIDES OFFERED BY KEY MARKET  PLAYERS 
                            ・       FIGURE 34......... SALES OF LINCOSAMIDES FOR FOOD-PRODUCING  ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 26. LINCOSAMIDES MARKET, BY COUNTRY, 2019–2026 (USD  MILLION) 
                            7.8             FLUOROQUINOLONES 
                            7.8.1              AVAILABILITY OF VARIATIONS IN THE ROUTE  OF ADMINISTRATION RESULTS IN THE HIGHER ADOPTION OF FLUOROQUINOLONES AMONG END  USERS 
                            ・       TABLE 27.. FLUOROQUINOLONES OFFERED BY KEY MARKET PLAYERS 
                            ・       FIGURE 35. SALES OF FLUOROQUINOLONES FOR FOOD-PRODUCING  ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 28. FLUOROQUINOLONES MARKET, BY COUNTRY, 2019–2026 (USD  MILLION) 
                            7.9             CEPHALOSPORINS 
                            7.9.1              CEPHALOSPORINS ARE ACTIVE AGAINST A WIDE  RANGE OF BACTERIA—A KEY FACTOR DRIVING MARKET GROWTH 
                            ・       TABLE 29.................... PROPERTIES OF SEVERAL GENERATIONS OF  CEPHALOSPORINS 
                            ・       TABLE 30...... CEPHALOSPORINS OFFERED BY KEY MARKET  PLAYERS 
                            ・       FIGURE 36................ SALES OF FIRST- AND SECOND-GENERATION  CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018  (MG/PCU) 
                            ・       FIGURE 37................ SALES OF THIRD- AND FOURTH-GENERATION  CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018  (MG/PCU) 
                            ・       TABLE 31..... CEPHALOSPORINS MARKET, BY COUNTRY,  2019–2026 (USD MILLION) 
                            7.10          OTHER ANTIMICROBIALS AND ANTIBIOTICS.. 102 
                            ・       FIGURE 38 SALES OF POLYMYXINS FOR FOOD-PRODUCING ANIMALS IN  EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU) 
                            ・       TABLE 32.... OTHER ANTIMICROBIALS AND ANTIBIOTICS  MARKET, BY COUNTRY, 
                            2019–2026 (USD MILLION)
8.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY
8.1             INTRODUCTION 
                            ・       TABLE 33... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  MODE OF DELIVERY, 2019–2026 (USD MILLION) 
8.2             PREMIXES 
                            8.2.1              ADVANTAGES OF  PREMIXES, SUCH AS SIMPLIFIED MODE OF ADMINISTRATION AND LOWER INSTABILITY AND HYGROSCOPICITY, 
                            TO DRIVE MARKET GROWTH 
                            ・       TABLE 34. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  PREMIXES, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            8.3             ORAL SOLUTIONS 
                            8.3.1              ORAL SOLUTIONS PRODUCE SYSTEMIC EFFECTS  BUT SHOW A RELATIVELY SLOW ONSET OF ACTION 
                            ・       TABLE 35. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  ORAL SOLUTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 
                            8.4             ORAL POWDERS 
                            8.4.1              PROPERTIES SUCH AS BETTER CHEMICAL STABILITY  THAN ORAL SOLUTIONS AND FASTER DISSOLUTION THAN ・       TABLETS AND CAPSULES TO DRIVE THE  ADOPTION OF ORAL POWDERS 
                            ・       TABLE 36. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  ORAL POWDERS, BY COUNTRY, 2019–2026 (USD MILLION) 
                            8.5             INJECTIONS 
                            8.5.1              INJEC・       TABLE DRUGS PROVIDE SYSTEMIC EFFECTS AND  POSSESS GREATER BIOAVAILABILITY, OFFERING A FASTER ONSET OF ACTION 
                            ・       TABLE 37. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  INJECTIONS, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            8.6             OTHER MODES OF DELIVERY 
                            ・       TABLE 38. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  OTHER MODES OF DELIVERY, BY COUNTRY, 2019–2026 (USD MILLION)
9.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL
9.1             INTRODUCTION 
                            ・       TABLE 39... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            9.2             FOOD-PRODUCING ANIMALS 
                            ・       TABLE 40..... GLOBAL POPULATION OF FOOD-PRODUCING  ANIMALS, 
                            1970–2030 (MILLION) 
                            ・       TABLE 41....... PER CAPITA CONSUMPTION OF MEAT IN MAJOR  APAC COUNTRIES, 
                            2019 (IN KG) 
                            ・       TABLE 42... ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION). 115 
                            ・       TABLE 43... ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR  FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.2.1              CATTLE 
                            9.2.1.1            INCREASING  BEEF CONSUMPTION AND MILK PRODUCTION TO DRIVE GROWTH IN THIS MARKET SEGMENT 
                            ・       TABLE 44. ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATTLE,  BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.2.2              PIGS 
                            9.2.2.1            GROWING  INCIDENCE OF ZOONOTIC DISEASES WILL REQUIRE BETTER HEALTH MAINTENANCE OF PIGS—A  KEY FACTOR DRIVING MARKET GROWTH 
                            ・       TABLE 45. ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PIGS, BY  COUNTRY, 
                            2019–2026 (USD MILLION) 
                            9.2.3              POULTRY 
                            9.2.3.1            GROWING EGG  CONSUMPTION IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH.. 118 
                            ・       FIGURE 39. LEADING EGG PRODUCING COUNTRIES, 2018 (NUMBER OF  EGGS, IN BILLION) 
                            ・       TABLE 46 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR POULTRY,  BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.2.4              SHEEP AND GOATS 
                            9.2.4.1            INCREASING  POPULATION OF SHEEP AND GOATS TO DRIVE GROWTH IN THIS SEGMENT 
                            ・       TABLE 47... ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR SHEEP AND  GOATS, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.2.5              OTHER  FOOD-PRODUCING ANIMALS 
                            ・       FIGURE 40........... PER CAPITA FISH CONSUMPTION, 2019 VS.  2029 
                            ・       TABLE 48... ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER  FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.3             COMPANION ANIMALS 
                            ・       TABLE 49............ ANTIMICROBIALS AND ANTIBIOTICS MARKET  FOR COMPANION ANIMALS, 
                            BY TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 50............ ANTIMICROBIALS AND ANTIBIOTICS MARKET  FOR COMPANION ANIMALS, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.3.1              DOGS 
                            9.3.1.1            GROWING ADOPTION  OF DOGS TO DRIVE GROWTH IN THIS MARKET SEGMENT 
                            ・       FIGURE 41. GROWING POPULATION OF PET DOGS IN INDIA (MILLION) 
                            ・       FIGURE 42............ POPULATION OF PET DOGS GLOBALLY  (MILLION) 
                            ・       TABLE 51 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR DOGS, BY  COUNTRY, 2019–2026 (USD MILLION) 
                            9.3.2              CATS 
                            9.3.2.1            GROWING  RESEARCH ON FELINE HEALTH AND WELLBEING TO SUPPORT THE MARKET GROWTH 
                            ・       TABLE 52 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATS, BY  COUNTRY, 
                            2019–2026 (USD MILLION) 
                            9.3.3              HORSES 
                            9.3.3.1            DECLINING  HORSE POPULATION NECESSITATES THE ADOPTION OF HEALTH PRODUCTS—A KEY FACTOR  DRIVING MARKET GROWTH 
                            ・       TABLE 53 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR HORSES,  BY COUNTRY, 2019–2026 (USD MILLION) 
                            9.3.4              OTHER COMPANION ANIMALS 
                            ・       TABLE 54... ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER  COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION). 129
10.. ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY REGION
10.1          INTRODUCTION 
                            ・       TABLE 55...... COMPANION ANIMAL AND FOOD-PRODUCING  ANIMAL POPULATION, 
                            BY COUNTRY, 2020 (IN THOUSAND) 
                            ・       TABLE 56... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY  REGION, 
                            2019–2026 (USD MILLION) 
                            10.2          NORTH AMERICA 
                            ・       FIGURE 43. EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN  NORTH AMERICA 
                            ・       FIGURE 44........... NORTH AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET SNAPSHOT 
                            ・       TABLE 57............. NORTH AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            ・       TABLE 58............. NORTH AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 59............. NORTH AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 60............. NORTH  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 61............. NORTH  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING  ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 62............. NORTH  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            10.2.1            US 
                            10.2.1.1          RISING PET  EXPENDITURE AND INCREASING MEAT CONSUMPTION ARE DRIVING THE MARKET IN THE US 
                            ・       FIGURE 45........ US: GROWTH IN BEEF CONSUMPTION,  2014–2019 (BILLION POUNDS) 
                            ・        FIGURE 46... US: INCREASE IN PET EXPENDITURE, 2010–2019 (USD  BILLION) 
                            ・       FIGURE 47...... DOMESTIC SALES AND DISTRIBUTION OF  MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS  IN THE US (THOUSAND KG) 
                            ・       TABLE 63. US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE,  2016 VS. 2018 
                            ・       TABLE 64. US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,  BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 65. US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 66. US: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 67.. US: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            ・       TABLE 68.. US: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026  (USD MILLION) 
                            10.2.2            CANADA 
                            10.2.2.1          GROWING PET  ADOPTION RATE TO DRIVE THE MARKET IN CANADA 
                            ・       TABLE 69...... CANADA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 70...... CANADA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 71...... CANADA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 72...... CANADA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 73...... CANADA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.3          EUROPE 
                            ・       TABLE 74...... EUROPE: LIVESTOCK POPULATION, BY ANIMAL,  2011–2018 (MILLION HEAD) 
                            ・       TABLE 75....... EUROPE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            ・       TABLE 76....... EUROPE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 77....... EUROPE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 78....... EUROPE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 79....... EUROPE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 80....... EUROPE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.3.1            SPAIN 
                            10.3.1.1          LARGE VOLUME  OF SALES OF IMPORTANT ANTIBIOTICS IN THIS COUNTRY TO DRIVE MARKET GROWTH 
                            ・       TABLE 81............ SPAIN: LARGE ANIMAL POPULATION,  2001–2019 (MILLION) 
                            ・       TABLE 82......... SPAIN: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 148 
                            ・       TABLE 83......... SPAIN: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 84......... SPAIN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 85......... SPAIN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 86......... SPAIN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.3.2            ITALY 
                            10.3.2.1          NEED TO CURB  ZOONOTIC DISEASES IN LIVESTOCK WILL CONTRIBUTE TO THE DEMAND FOR ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET IN ITALY 
                            ・       TABLE 87.......... ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 88.......... ITALY: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 89.......... ITALY:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 90 ITALY: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            ・       TABLE 91 ITALY: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026  (USD MILLION) 
                            10.3.3            GERMANY 
                            10.3.3.1          INCREASING  NUMBER OF PETS, INCREASING VETERINARY VISITS, AND GROWING HEALTHCARE  EXPENDITURE TO BOOST THE GROWTH OF THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET IN GERMANY 
                            ・       TABLE 92 GERMANY: COMPANION ANIMAL POPULATION, 2012–2018  (MILLION) 
                            ・       FIGURE 48............ SALES SURVEILLANCE OF ANTIMICROBIALS FOR  VETERINARY USE IN GERMANY (2011 TO 2018) 
                            ・       TABLE 93.... GERMANY: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 94.... GERMANY: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 95.... GERMANY:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 96.... GERMANY:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 97.... GERMANY:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.3.4            FRANCE 
                            10.3.4.1          PRESENCE OF  MAJOR PLAYERS HAS ENSURED THE STRONG SHARE OF FRANCE IN THE OVERALL MARKET 
                            ・       TABLE 98....... FRANCE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 99....... FRANCE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 100..... FRANCE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 101..... FRANCE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE  102..... FRANCE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.3.5            UK 
                            10.3.5.1          INCREASING PET  OWNERSHIP IS EXPECTED TO DRIVE MARKET GROWTH 
                            ・       FIGURE 49 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN  THE UK FROM 2015 TO 2019 (MG/KG) 
                            ・       TABLE 103 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,  BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 104 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 105 UK: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 106 UK: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            ・       TABLE 107 UK: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026  (USD MILLION) 
                            10.3.6            REST OF EUROPE 
                            ・       TABLE 108.......... ROE: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 162 
                            ・       TABLE 109.......... ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 110.......... ROE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
                            ・       TABLE 111.......... ROE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
                            ・       TABLE 112.......... ROE:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
                            10.4          ASIA PACIFIC (APAC) 
                            ・       TABLE 113.. ASIA PACIFIC: FOOD-PRODUCING ANIMAL POPULATION, 
                            2010–2017 (MILLION) 
                            ・       FIGURE 50............... ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET SNAPSHOT 
                            ・       TABLE 114............... ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY COUNTRY, 2019–2026 (USD MILLION) 
                            ・       TABLE 115............... ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY PRODUCT, 2019–2026 (USD MILLION) 
                            ・       TABLE 116............... ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
                            BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
                            ・       TABLE 117............... ASIA  PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
                            BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 118. ASIA PACIFIC:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
・       TABLE 119. ASIA PACIFIC: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026  (USD MILLION) 
10.4.1            CHINA 
10.4.1.1          CHINA  DOMINATES THE APAC ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET 
・       TABLE 120. CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019  (MILLION) 
・       TABLE 121....... CHINA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 169 
・       TABLE 122....... CHINA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 123....... CHINA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 124....... CHINA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
・       TABLE 125....... CHINA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
10.4.2            JAPAN 
10.4.2.1          RISING DEMAND  FOR IMPORTED BREEDS IS DRIVING PET ADOPTION IN THE COUNTRY 
・       TABLE 126.. PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD  PRODUCTS 
IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS) 
・       FIGURE 51..... VOLUMES OF VETERINARY ANTIMICROBIALS  SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE  INGREDIENT) 
・       FIGURE 52............... AMOUNT OF ANTIMICROBIAL FEED ADDITIVES  MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT) 
・       TABLE 127....... JAPAN: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 173 
・       TABLE 128....... JAPAN: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 129....... JAPAN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 130....... JAPAN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
・       TABLE 131....... JAPAN:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
10.4.3            INDIA 
10.4.3.1          RISING  FOOD-PRODUCING ANIMAL POPULATION AND GROWING AWARENESS ABOUT ANIMAL HEALTH WILL  CONTRIBUTE TO MARKET GROWTH DURING THE FORECAST PERIOD.. 175 
・       TABLE 132.. PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD  PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS). 176 
・       TABLE 133........ INDIA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 176 
・       TABLE 134........ INDIA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 135........ INDIA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 136........ INDIA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
・       TABLE 137........ INDIA:  ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2019–2026 (USD MILLION) 
10.4.4            REST OF ASIA PACIFIC (REST OF APAC) 
・       TABLE 138........... REGULATORY SCENARIO FOR ANTIBIOTICS IN  THE ROAPAC, BY COUNTRY 
・       TABLE 139.............. REST OF APAC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY PRODUCT, 2019–2026 (USD MILLION) 
・       TABLE 140.............. REST OF APAC: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 141.............. REST OF  APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 142.............. REST OF  APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS,  BY TYPE, 2019–2026 (USD MILLION) 
・       TABLE 143.............. REST OF  APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
10.5          LATIN AMERICA 
・       TABLE 144............... LATIN AMERICA: FOOD-PRODUCING ANIMALS  POPULATION, BY COUNTRY (2010–2014) (MILLION) 
・       TABLE 145............ LATIN AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY PRODUCT, 2019–2026 (USD MILLION) 
・       TABLE 146............ LATIN AMERICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, 
BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 147............ LATIN  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 
BY TYPE OF ANIMAL, 2019–2026 (USD MILLION) 
・       TABLE 148............ LATIN  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING  ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 
・       TABLE 149............ LATIN  AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY  TYPE, 2019–2026 (USD MILLION) 
10.6          MIDDLE EAST & AFRICA 
・       TABLE 150 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS.  2016 
・       TABLE 151.. MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION). 184 
・       TABLE 152.. MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 
・       TABLE 153.. MIDDLE EAST &  AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL,  2019–2026 (USD MILLION) 
・       TABLE 154.. MIDDLE EAST &  AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING  ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 
・       TABLE 155.. MIDDLE EAST &  AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY  TYPE, 2019–2026 (USD MILLION)
11.. COMPETITIVE LANDSCAPE
11.1          INTRODUCTION 
                            ・       FIGURE 53 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND  JAN 2021 
                            11.2          MARKET EVALUATION FRAMEWORK 
                            ・       FIGURE 54. MARKET EVALUATION FRAMEWORK: ACQUISITIONS—THE MOST  WIDELY ADOPTED STRATEGY 
                            11.3          PRODUCT PORTFOLIO MATRIX 
                            ・       TABLE 156............. PLAYERS IN THE ANIMAL ANTIMICROBIALS AND  ANTIBIOTICS MARKET: PRODUCT PORTFOLIO ANALYSIS 
                            11.4          ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHICAL  ASSESSMENT 
                            ・       FIGURE 55....... GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN  THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019). 191 
                            11.5          ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: R&D  EXPENDITURE 
                            ・       FIGURE 56........ R&D EXPENDITURE OF KEY PLAYERS IN  THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019) 192 
                            11.6          REVENUE ANALYSIS: TOP 5 PLAYERS 
                            ・       FIGURE 57.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: REVENUE ANALYSIS (2019) 
                            11.7          VENDOR DIVE 
                            11.7.1            STARS 
                            11.7.2            EMERGING LEADERS.. 194 
                            11.7.3            PERVASIVE PLAYERS.. 194 
                            11.7.4            EMERGING COMPANIES 
                            ・       FIGURE 58.............. COMPETITIVE LEADERSHIP MAPPING: ANIMAL  ANTIMICROBIALS AND ANTIBIOTICS MARKET, 2020 
                            11.8          MARKET SHARE ANALYSIS 
                            ・       TABLE 157..... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: DEGREE OF COMPETITION 
                            ・       FIGURE 59..... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET SHARE ANALYSIS, 
                            BY KEY PLAYER, 2020 
                            11.9          COMPETITIVE SITUATION AND TRENDS 
                            11.9.1            PRODUCT LAUNCHES & APPROVALS 
                            ・       TABLE 158........................... PRODUCT LAUNCHES & APPROVALS 
                            11.9.2            PARTNERSHIPS, AGREEMENTS, AND  COLLABORATIONS 
                            ・       TABLE 159... PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 
                            11.9.3            MERGERS, ACQUISITIONS, AND DIVESTITURES 
                            ・       TABLE 160.............. MERGERS, ACQUISITIONS, AND DIVESTITURES 
                            11.9.4            EXPANSIONS 
                            ・       TABLE 161......................................................... EXPANSIONS 
                            11.10        SME MATRIX 
                            11.10.1         COMPETITIVE LEADERSHIP MAPPING (SMES) 
                            11.10.1.1        PROGRESSIVE  COMPANIES 
                            11.10.1.2        STARTING BLOCKS 
                            11.10.1.3        RESPONSIVE  COMPANIES 
                            11.10.1.4        DYNAMIC  COMPANIES 
                            ・       FIGURE 60.... ANIMAL ANTIMICROBIALS AND ANTIBIOTICS  MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SME, 2020
12.. COMPETITIVE EVALUATION MATRIX AND COMPANY PROFILES
12.1          KEY PLAYERS
                            (BUSINESS OVERVIEW, PRODUCTS OFFERED,  RECENT DEVELOPMENTS, MNM VIEW)*
                            12.1.1            ZOETIS, INC. 
                            ・       TABLE 162............................. ZOETIS, INC.: BUSINESS OVERVIEW 
                            ・       FIGURE 61......................... ZOETIS: COMPANY SNAPSHOT (2019) 
                            12.1.2            MERCK & CO., INC. 
                            ・       TABLE 163................. MERCK AND CO., INC: BUSINESS OVERVIEW 
                            ・       FIGURE 62.......... MERCK & CO., INC.: COMPANY SNAPSHOT  (2019) 
                            12.1.3            BOEHRINGER INGELHEIM GMBH 
                            ・       TABLE 164... BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW 
                            ・       FIGURE 63.. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2019) 
                            12.1.4            ELANCO ANIMAL HEALTH 
                            ・       TABLE 165............. ELANCO ANIMAL HEALTH: BUSINESS OVERVIEW 
                            ・       FIGURE 64.. ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT (2019) 
                            12.1.5            CEVA SANTÉ ANIMALE 
                            ・       TABLE 166................ CEVA SANTÉ ANIMALE: BUSINESS OVERVIEW 
                            12.1.6            VIRBAC 
                            ・       TABLE 167................................... VIRBAC: BUSINESS OVERVIEW 
                            ・       FIGURE 65......................... VIRBAC: COMPANY SNAPSHOT (2019) 
                            12.1.7            VETOQUINOL SA. 
                            ・       TABLE 168...................... VETOQUINOL S.A.: BUSINESS OVERVIEW 
                            ・       FIGURE 66.............. VETOQUINOL SA: COMPANY SNAPSHOT (2019) 
                            12.1.8            DECHRA PHARMACEUTICALS PLC 
                            ・       TABLE 169. DECHRA PHARMACEUTICALS PLC: BUSINESS OVERVIEW 
                            ・       FIGURE 67. DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2019) 
                            12.1.9            PHIBRO ANIMAL HEALTH 
                            ・       TABLE 170............. PHIBRO ANIMAL HEALTH: BUSINESS OVERVIEW 
                            ・       FIGURE 68... PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019) 
                            12.1.10         KYORITSU SEIYAKU 
                            ・       TABLE 171.................... KYORITSU SEIYAKU: BUSINESS OVERVIEW 
                            12.1.11         ZYDUS ANIMAL HEALTH 
                            ・       TABLE 172............... ZYDUS ANIMAL HEALTH: BUSINESS OVERVIEW 
                            ・       FIGURE 69.......................... ZYDUS: COMPANY SNAPSHOT (2019) 
                            12.1.12         TIANJIN RINGPU 
                            ・       TABLE 173........................ TIANJIN RINGPU: BUSINESS OVERVIEW 
                            12.1.13         HIPRA 
                            ・       TABLE 174..................................... HIPRA: BUSINESS OVERVIEW 
                            12.1.14         CHINA ANIMAL HUSBANDRY 
                            ・       TABLE 175........ CHINA ANIMAL HUSBANDRY: BUSINESS  OVERVIEW 
                            12.1.15         INOVET 
                            ・       TABLE 176......... INOVET: BUSINESS OVERVIEW
                            *BUSINESS OVERVIEW, PRODUCTS OFFERED,  RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED  COMPANIES.
                            12.2          OTHER EMERGING COMPANIES 
                            12.2.1            ENDOVAC ANIMAL HEALTH 
                            12.2.2            ECO ANIMAL HEALTH GROUP PLC 
                            12.2.3            INDIAN IMMUNOLOGICALS LTD. 
                            12.2.4            ASHISH LIFE SCIENCE (ALS) 
                            12.2.5            LUTIM PHARMA 
                            13.. APPENDIX 
掲載企業リスト
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。
                            
                          

HOME

お問合わせはこちらから